首页> 外国专利> NOVEL ISOXAZOLE DERIVATIVES, PROCESS FOR PRODUCING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

NOVEL ISOXAZOLE DERIVATIVES, PROCESS FOR PRODUCING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

机译:新型异恶唑衍生物,制备它们的方法和包含相同异药的药物组合物

摘要

the invention relates to a new formula (i) u00e1ltalu00e1nu0151s izu0151xazu0151l - szu00e1rmazu00e9ku0151k, azelu0151u00e1llu00edtu00e1su0171kra szu0151lgu00e1lu00f3 procedure and form such hatu00f3anyagu0151t tartalmazu00f3gyu00f3gyu00e1szati preparations.in the formula (i) u00e1ltalu00e1nu0151s individually or in combination, and bjelentu00e9se hidru0151gu00e9natu0151m vegyu00e9rtu00e9kku00f6tu00e9s, z's report hidru0151gu00e9natu0151m, halu0151gu00e9natu0151m, 1 - 4 - methyl - szu00e9natu0151mu0151s alkilcsu0151pu0151rt, triflu0171u0151r csu0151pu0151rt,or one or two 1 - 4 szu00e9natu0151mu0151salku0151xicsu0151pu0151rt report, r1 and r2 independently of each other, szu00e9natu0151mu0151s alkilcsu0151pu0151rt 1 - 6, or 3 - 7 - szu00e9natu0151mu0151s ciklu0151alkilcsu0151pu0151rt, or r1 and r2 anitru0151gu00e9natu0151mmal,in which case, a kapcsu0151lu00f3dnak, and adu0151tt or tu00f6bbtu0151vu00e1bbi nitru0151gu00e9n - and / or u0151xigu00e9natu0151mmal together constitute a heteru0151ciklu0171su0151sgyu0171ru0171t of 5 to 8, which is 1 - 4 szu00e9natu0151mu0151s alkilcsu0151pu0151rttal,(1 - 4 - phenyl - csu0151pu0151rttal szu00e9natu0151mu0151salkil) (1 - 4 - phenyl - csu0151pu0151rttal szu00e9natu0151mu0151s alku0151xi), di (1 - 4 - phenyl - csu0151pu0151rttal szu00e9natu0151mu0151s alku0151xi), halu0151gu00e9n - phenyl - csu0151pu0151rttal,(triflu0171u0151r - methyl) - phenyl - or fu0171ru0151ilcsu0151pu0151rttal csu0151pu0151rttal lehethelyettesu00edtve value, m is 0 or 1, n is 0 or 1, with the condition of hu0151gy 1) if a and b vegyu00e9rtu00e9kku00f6tu00e9s report jointly.the value of m 0, tu0151vu00e1bbu00e1r1 and report each other as etilcsu0151pu0151rt r2 or r1 and r2 together with the anitru0151gu00e9natu0151mmal - which kapcsu0151lu00f3dnak - piperidin-1-yl - vagymu0151rfu0151linu0151 - csu0151pu0151rtu0151t constituteakku0151r z's report hidru0151gu00e9natu0151mtu00f3l u00e9spara favoured klu00f3ratu0151mtu00f3l different, and (2) if a and b vegyu00e9rtu00e9kku00f6tu00e9s report jointly, and r2 value of m 0, tu0151vu00e1bbu00e1r1 report each other as metilcsu0151pu0151rt,anitru0151gu00e9natu0151mmal or r1 and r2 together, to which kapcsu0151lu00f3dnak - pirru0151lidin - 1 - il - csu0151pu0151rtu0151t constitute, akku0151r z hidru0151gu00e9natu0151mtu00f3l meaning is different.in accordance with atalu00e1lmu00e1ny compounds linked to the nervous system or ku00f6zpu0151nti a1u00e9s / 5 - ht1a receptu0151ru0151khu0151z; pszichu0151tru00f3p and kardiu0151vaszku0171lu00e1rishatu00e1su0151kkal characteristics. a
机译:本发明涉及一种新的公式(i) u00e1ltal u00e1n u0151s iz u0151xaz u0151l-sz u00e1rmaz u00e9k u0151k,azel u0151 u00e1ll u00edt u00e1s u0171lg sz u001l形式(i) i u00e1ltal u00e1n u0151s单独或组合使用,并且bjelent u00e9se hidr u0151g u00e9nat u00e9nat u00e3naag u0151t tartalmaz u00f3gy u00f3gy u00e1szati​​制剂u00f6t u00e9s,z的报告hidr u0151g u00e9nat u0151m,hal u0151g u00e9nat u0151m,1-4-甲基-sz u00e9nat u0151m u0151s alkilcsu u0151p u0151r, u0151rt或一个或两个1-4 sz u00e9nat u0151m u0151salk u0151xics u0151p u0151rt报告,r1和r2彼此独立,sz u00e9nat u0151m u0151s alkilcs u0151p 6,or0153rt 1 -7-sz u00e9nat u0151m u0151s cikl u0151alkilcs u0151p u0151rt或r1和r2 anitr u0151g u00e9nat u0151mmal,在这种情况下,为kapcs u0151l u00f3dnak和ad u0151v u00e1bbi硝基 u0151 g u00e9n-和 /或 u0151xig u00e9nat u0151mm一起构成5到8的杂种 u0151cikl u0171s u0151sgy u0171r u0171t,即1-4 sz u00e9nat u0151m u0151s alkiltal ,(1-4-苯基-cs u0151p u0151rttal sz u00e9nat u0151m u0151salkil)(1-4-苯基-cs u0151p u0151rttal sz u00e9nat u0151m u0151s alk u0151xi 4 -苯基-cs u0151p u0151rttal sz u00e9nat u0151m u0151s alk u0151xi),hal u0151g u00e9n-苯基-cs u0151p u0151rttal,(trifl u0171 u0151r-甲基)-苯基- u0151ilcs u0151p u0151rttal cs u0151p u0151rttal lehethelyettes u00edtve值,m为0或1,n为0或1,条件为h u0151gy 1)如果a和b vegy u00e9rt u00e9kk u00f6t共同报告m 0的值t u0151v u00e1bb u00e1r1并相互报告为etilcs u0151p u0151rt r2或r1和r2以及anitr u0151g u00e9nat u0151mmal-kapcs u0151l u00f3dnak- -1-yl-vagym u0151rf u0151lin u0151-cs u0151p u0151rt u0151t const ituteakk u0151r z的报告hidr u0151g u00e9nat u0151mt u00f3l u00e9spara赞成kl u00f3rat u0151mt u00f3l不同,并且(2)如果a和b vegy u00e9rt u00e9kk和u00f6t的合计值m 0,t u0151v u00e1bb u00e1r1彼此报告为metilcs u0151p u0151rt,anitr u0151g r00和r1和r2,kapcs u0151l u00f3dnak-pirr u0151lidin- u0151p u0151rt u0151t构成,akk u0151r z hidr u0151g u00e9nat u0151mt u00f3l的含义不同。根据与神经系统或k u00f6zp u0151nti关联的化合物atal u00e1lm u00e3ny 5-ht1a接收器 u0151r u0151kh u0151z; pszich u0151tr u00f3p和kardi u0151vaszk u0171l u00e1rishat u00e1s u0151kkal特性。一种

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号